Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Apr 06, 2023 $13.40 $14.00 $13.34 $13.59 1 459 081
Apr 05, 2023 $13.19 $13.46 $13.01 $13.34 1 360 920
Apr 04, 2023 $14.51 $14.92 $13.23 $13.37 1 023 807
Apr 03, 2023 $14.28 $14.94 $14.00 $14.41 823 109
Mar 31, 2023 $14.52 $14.84 $14.19 $14.42 1 039 550
Mar 30, 2023 $15.00 $15.06 $13.99 $14.30 649 431
Mar 29, 2023 $14.63 $14.95 $14.33 $14.78 619 011
Mar 28, 2023 $14.59 $14.95 $14.32 $14.35 486 441
Mar 27, 2023 $14.53 $14.83 $14.40 $14.67 587 416
Mar 24, 2023 $14.19 $14.57 $13.81 $14.42 648 448
Mar 23, 2023 $15.47 $15.66 $14.19 $14.35 761 812
Mar 22, 2023 $16.69 $16.69 $15.19 $15.22 614 905
Mar 21, 2023 $16.45 $17.06 $16.36 $16.69 763 161
Mar 20, 2023 $16.73 $16.73 $16.10 $16.35 560 686
Mar 17, 2023 $16.81 $16.90 $16.30 $16.48 2 037 739
Mar 16, 2023 $16.91 $17.21 $16.70 $16.92 836 444
Mar 15, 2023 $16.98 $17.29 $16.66 $17.05 779 571
Mar 14, 2023 $18.46 $18.66 $17.09 $17.42 634 223
Mar 13, 2023 $16.74 $18.32 $16.36 $17.85 1 114 278
Mar 10, 2023 $17.32 $17.47 $15.82 $17.08 1 381 493
Mar 09, 2023 $17.98 $18.50 $17.15 $17.39 743 195
Mar 08, 2023 $18.87 $19.03 $17.97 $18.22 664 468
Mar 07, 2023 $18.73 $19.03 $18.30 $18.75 906 027
Mar 06, 2023 $19.51 $19.54 $18.44 $18.81 978 517
Mar 03, 2023 $20.90 $20.97 $19.41 $19.47 1 440 981
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT